The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cefixime Nectar Lifesciences 100 mg/5 ml Powder for Oral Suspension



NECLIFE PT UNIPESSOAL LDAPA22914/001/001

Main Information

Trade NameCefixime Nectar Lifesciences 100 mg/5 ml Powder for Oral Suspension
Active SubstancesCefixime
Dosage FormPowder for oral suspension
Licence HolderNECLIFE PT UNIPESSOAL LDA
Licence NumberPA22914/001/001

Group Information

ATC CodeJ01DA08 CEFACLOR

Status

License statusAuthorised
Licence Issued16/11/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back